Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
1.92 USD | +1.05% | -11.93% | -33.79% |
15/05 | Humana Is First Commercial Payer to Address TMS Therapy Coverage for Adolescents | CI |
14/05 | William Blair Upgrades Neuronetics to Outperform From Market Perform | MT |
Sales 2024 * | 7.91Cr 660.14Cr | Sales 2025 * | 8.98Cr 749.3Cr | Capitalization | 5.76Cr 480.41Cr |
---|---|---|---|---|---|
Net income 2024 * | -2.7Cr -225.21Cr | Net income 2025 * | -2Cr -166.82Cr | EV / Sales 2024 * | 0.73 x |
Net cash position 2024 * | - 0 | Net cash position 2025 * | - 0 | EV / Sales 2025 * | 0.64 x |
P/E ratio 2024 * |
-2.08
x | P/E ratio 2025 * |
-2.97
x | Employees | 202 |
Yield 2024 * |
-
| Yield 2025 * |
-
| Free-Float | 93.69% |
Latest transcript on Neuronetics, Inc.
1 day | +1.05% | ||
1 week | -11.93% | ||
1 month | -45.14% | ||
3 months | -36.21% | ||
6 months | -5.42% | ||
Current year | -33.79% |
Managers | Title | Age | Since |
---|---|---|---|
Keith Sullivan
CEO | Chief Executive Officer | 65 | 14/20/14 |
Stephen Furlong
DFI | Director of Finance/CFO | 60 | - |
Cory Anderson
CTO | Chief Tech/Sci/R&D Officer | - | 01/21/01 |
Members of the board | Title | Age | Since |
---|---|---|---|
Robert Cascella
CHM | Chairman | 69 | 01/21/01 |
Sheryl Conley
BRD | Director/Board Member | 63 | 01/19/01 |
Glenn Muir
BRD | Director/Board Member | 65 | 01/17/01 |
Date | Price | Change | Volume |
---|---|---|---|
31/24/31 | 1.92 | +1.05% | 130,596 |
30/24/30 | 1.9 | -6.86% | 672,041 |
29/24/29 | 2.04 | -1.92% | 95,720 |
28/24/28 | 2.08 | -4.59% | 67,425 |
Delayed Quote Nasdaq, May 01, 2024 at 01:30 am IST
More quotesEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-33.79% | 5.76Cr | |
+7.01% | 22TCr | |
+11.01% | 19TCr | |
+19.20% | 14TCr | |
+30.79% | 11TCr | |
+1.48% | 6.46TCr | |
+13.95% | 5.24TCr | |
-0.16% | 4.85TCr | |
-6.20% | 3.8TCr | |
+0.91% | 3.56TCr |
- Stock Market
- Equities
- STIM Stock